REIT - Residential
Compare Stocks
2 / 10Stock Comparison
IRT vs NMR
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Capital Markets
IRT vs NMR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | REIT - Residential | Financial - Capital Markets |
| Market Cap | $3.87B | $23.56B |
| Revenue (TTM) | $662M | $4.76T |
| Net Income (TTM) | $48M | $370.05B |
| Gross Margin | 20.2% | 45.6% |
| Operating Margin | 17.5% | 11.3% |
| Forward P/E | 100.2x | 10.0x |
| Total Debt | $2.28B | $17.30T |
| Cash & Equiv. | $48M | $4.30T |
IRT vs NMR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Independence Realty… (IRT) | 100 | 166.0 | +66.0% |
| Nomura Holdings, In… (NMR) | 100 | 191.5 | +91.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IRT vs NMR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IRT is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 4 yrs, beta 0.48, yield 4.0%
- 198.6% 10Y total return vs NMR's 146.3%
- Lower volatility, beta 0.48, Low D/E 63.6%, current ratio 0.05x
NMR carries the broadest edge in this set and is the clearest fit for growth exposure and defensive.
- Rev growth 5.6%, EPS growth 7.2%
- Beta 1.32, yield 4.6%, current ratio 1.43x
- 5.6% NII/revenue growth vs IRT's 2.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 5.6% NII/revenue growth vs IRT's 2.8% | |
| Value | Lower P/E (10.0x vs 100.2x) | |
| Quality / Margins | 7.6% margin vs IRT's 7.3% | |
| Stability / Safety | Beta 0.48 vs NMR's 1.32, lower leverage | |
| Dividends | 4.6% yield, 3-year raise streak, vs IRT's 4.0% | |
| Momentum (1Y) | +51.0% vs IRT's -11.8% | |
| Efficiency (ROA) | 0.8% ROA vs NMR's 0.6%, ROIC 1.6% vs 1.4% |
IRT vs NMR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
IRT vs NMR — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
NMR leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
NMR is the larger business by revenue, generating $4.76T annually — 7190.5x IRT's $662M. Profitability is closely matched — net margins range from 7.6% (NMR) to 7.3% (IRT).
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $662M | $4.76T |
| EBITDAEarnings before interest/tax | $365M | $533.0B |
| Net IncomeAfter-tax profit | $48M | $370.1B |
| Free Cash FlowCash after capex | $139M | $0 |
| Gross MarginGross profit ÷ Revenue | +20.2% | +45.6% |
| Operating MarginEBIT ÷ Revenue | +17.5% | +11.3% |
| Net MarginNet income ÷ Revenue | +7.3% | +7.6% |
| FCF MarginFCF ÷ Revenue | +21.1% | -25.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.5% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -101.4% | -5.5% |
Valuation Metrics
NMR leads this category, winning 4 of 5 comparable metrics.
Valuation Metrics
At 10.7x trailing earnings, NMR trades at a 84% valuation discount to IRT's 68.4x P/E. On an enterprise value basis, IRT's 16.7x EV/EBITDA is more attractive than NMR's 27.4x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $3.9B | $23.6B |
| Enterprise ValueMkt cap + debt − cash | $6.1B | $106.8B |
| Trailing P/EPrice ÷ TTM EPS | 68.42x | 10.71x |
| Forward P/EPrice ÷ next-FY EPS est. | 100.18x | 9.99x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.55x |
| EV / EBITDAEnterprise value multiple | 16.75x | 27.43x |
| Price / SalesMarket cap ÷ Revenue | 5.88x | 0.77x |
| Price / BookPrice ÷ Book value/share | 1.07x | 1.01x |
| Price / FCFMarket cap ÷ FCF | 26.41x | — |
Profitability & Efficiency
IRT leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
NMR delivers a 10.2% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $1 for IRT. IRT carries lower financial leverage with a 0.64x debt-to-equity ratio, signaling a more conservative balance sheet compared to NMR's 4.49x. On the Piotroski fundamental quality scale (0–9), IRT scores 6/9 vs NMR's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +1.3% | +10.2% |
| ROA (TTM)Return on assets | +0.8% | +0.6% |
| ROICReturn on invested capital | +1.6% | +1.4% |
| ROCEReturn on capital employed | +2.4% | +2.4% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.64x | 4.49x |
| Net DebtTotal debt minus cash | $2.2B | $13.00T |
| Cash & Equiv.Liquid assets | $48M | $4.30T |
| Total DebtShort + long-term debt | $2.3B | $17.30T |
| Interest CoverageEBIT ÷ Interest expense | 1.73x | 0.20x |
Total Returns (Dividends Reinvested)
NMR leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NMR five years ago would be worth $16,867 today (with dividends reinvested), compared to $12,002 for IRT. Over the past 12 months, NMR leads with a +51.0% total return vs IRT's -11.8%. The 3-year compound annual growth rate (CAGR) favors NMR at 36.1% vs IRT's 2.5% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -5.7% | -3.4% |
| 1-Year ReturnPast 12 months | -11.8% | +51.0% |
| 3-Year ReturnCumulative with dividends | +7.7% | +152.1% |
| 5-Year ReturnCumulative with dividends | +20.0% | +68.7% |
| 10-Year ReturnCumulative with dividends | +198.6% | +146.3% |
| CAGR (3Y)Annualised 3-year return | +2.5% | +36.1% |
Risk & Volatility
Evenly matched — IRT and NMR each lead in 1 of 2 comparable metrics.
Risk & Volatility
IRT is the less volatile stock with a 0.48 beta — it tends to amplify market swings less than NMR's 1.32 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.48x | 1.32x |
| 52-Week HighHighest price in past year | $19.61 | $9.58 |
| 52-Week LowLowest price in past year | $14.60 | $5.48 |
| % of 52W HighCurrent price vs 52-week peak | +83.7% | +85.2% |
| RSI (14)Momentum oscillator 0–100 | 65.0 | 44.4 |
| Avg Volume (50D)Average daily shares traded | 2.2M | 2.1M |
Analyst Outlook
Evenly matched — IRT and NMR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates IRT as "Buy" and NMR as "Hold". Consensus price targets imply 22.3% upside for IRT (target: $20) vs -29.0% for NMR (target: $6). For income investors, NMR offers the higher dividend yield at 4.63% vs IRT's 4.01%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $20.08 | $5.79 |
| # AnalystsCovering analysts | 27 | 9 |
| Dividend YieldAnnual dividend ÷ price | +4.0% | +4.6% |
| Dividend StreakConsecutive years of raises | 4 | 3 |
| Dividend / ShareAnnual DPS | $0.66 | $59.06 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.8% | +2.8% |
NMR leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). IRT leads in 1 (Profitability & Efficiency). 2 tied.
IRT vs NMR: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is IRT or NMR a better buy right now?
For growth investors, Nomura Holdings, Inc.
(NMR) is the stronger pick with 5. 6% revenue growth year-over-year, versus 2. 8% for Independence Realty Trust, Inc. (IRT). Nomura Holdings, Inc. (NMR) offers the better valuation at 10. 7x trailing P/E (10. 0x forward), making it the more compelling value choice. Analysts rate Independence Realty Trust, Inc. (IRT) a "Buy" — based on 27 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IRT or NMR?
On trailing P/E, Nomura Holdings, Inc.
(NMR) is the cheapest at 10. 7x versus Independence Realty Trust, Inc. at 68. 4x. On forward P/E, Nomura Holdings, Inc. is actually cheaper at 10. 0x.
03Which is the better long-term investment — IRT or NMR?
Over the past 5 years, Nomura Holdings, Inc.
(NMR) delivered a total return of +68. 7%, compared to +20. 0% for Independence Realty Trust, Inc. (IRT). Over 10 years, the gap is even starker: IRT returned +198. 6% versus NMR's +146. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IRT or NMR?
By beta (market sensitivity over 5 years), Independence Realty Trust, Inc.
(IRT) is the lower-risk stock at 0. 48β versus Nomura Holdings, Inc. 's 1. 32β — meaning NMR is approximately 174% more volatile than IRT relative to the S&P 500. On balance sheet safety, Independence Realty Trust, Inc. (IRT) carries a lower debt/equity ratio of 64% versus 4% for Nomura Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — IRT or NMR?
By revenue growth (latest reported year), Nomura Holdings, Inc.
(NMR) is pulling ahead at 5. 6% versus 2. 8% for Independence Realty Trust, Inc. (IRT). On earnings-per-share growth, the picture is similar: Independence Realty Trust, Inc. grew EPS 41. 2% year-over-year, compared to 7. 2% for Nomura Holdings, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IRT or NMR?
Independence Realty Trust, Inc.
(IRT) is the more profitable company, earning 8. 6% net margin versus 7. 6% for Nomura Holdings, Inc. — meaning it keeps 8. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IRT leads at 18. 4% versus 11. 3% for NMR. At the gross margin level — before operating expenses — NMR leads at 45. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IRT or NMR more undervalued right now?
On forward earnings alone, Nomura Holdings, Inc.
(NMR) trades at 10. 0x forward P/E versus 100. 2x for Independence Realty Trust, Inc. — 90. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IRT: 22. 3% to $20. 08.
08Which pays a better dividend — IRT or NMR?
All stocks in this comparison pay dividends.
Nomura Holdings, Inc. (NMR) offers the highest yield at 4. 6%, versus 4. 0% for Independence Realty Trust, Inc. (IRT).
09Is IRT or NMR better for a retirement portfolio?
For long-horizon retirement investors, Independence Realty Trust, Inc.
(IRT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 48), 4. 0% yield, +198. 6% 10Y return). Both have compounded well over 10 years (IRT: +198. 6%, NMR: +146. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IRT and NMR?
These companies operate in different sectors (IRT (Real Estate) and NMR (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: IRT is a small-cap income-oriented stock; NMR is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.